hotspot -WSS

hotspot

author：entertainment 2025-09-27 22:46:14 - browse：8721

Tortoise and hare — Medical devices have historically been seen as having faster paths to market than their pharmacological counterparts. The growing requirement for cost-effectiveness trials may be slowing them down. Jonathan Elderfield/AP

When a colleague and I started our medical device company in 2009, we were in our second year at Harvard Medical School. Some classmates joked that they would still be in residency by the time we had moved on to our next big idea. We knew better — we expected it to be a long haul. Eight years into our journey, thousands of individuals have used our product in countries where it has been approved. But we have yet to gain approval in the U.S. — a long and expensive process.

In 2016, the United States Food and Drug Administration approved 22 new drugs, down from 45 approvals in 2015. The decline in drug discovery has been attributed to a variety of factors that include ballooning research and development expenses (the cost to develop a new drug is now estimated to be more than $2.5 billion), high rates of failure (a whopping 90 percent of Phase 1 candidates never make it to launch), and the complexity of human biology, which can thwart even the most promising candidates.

Medical devices have historically been viewed as having faster and lower-cost paths to market than their pharmacological counterparts: the average cost to develop high-risk, novel medical devices is estimated to be $94 million. After all, device engineers can leverage lower-cost animal models further into development than their pharmaceutical colleagues, the human clinical trials necessary for FDA approval are often smaller in scale, and, in some cases, expenses can be defrayed by revenue generated outside the United States in markets with faster regulatory pathways.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： The high cost of giving birth even with insurance
Next article： FDA’s Peter Marks seems inclined to back Sarepta’s gene therapy

hotspot

Wikipedia

WSS

The SUPPORT Act is critical to fighting the opioid crisis

Mississippi candidates for statewide offices square off in party primaries

Elon Musk says he may need surgery before proposed 'cage match' with Mark Zuckerberg

Caregivers of transplant patients call for more support, training

Tesla CFO Zachary Kirkhorn steps down, but will remain with company through year's end

Readout LOUD podcast: live from JPM 2024

knowledge

hotspot

knowledge

Malaria cases in Florida and Texas: Here’s what you need to know

Readout LOUD podcast: FTC v. biotech, future of Pfizer and Vertex

As demand for Covid shots wanes, Moderna seeks its next success

Risky weight loss products often used by teens globally, per study

Medicare details structure of new drug price negotiation program

Biden will tout long

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

The nurse manager staffing crisis is hurting patients

Duchenne breakthrough therapy leaves behind pioneering families

Appeals court upholds Josh Duggar's conviction for downloading child sex abuse images

entertainment

Boeing's 1st astronaut flight bumped into next year, more repairs needed

Doudna institute plans to 'cure hundreds of diseases' with CRISPR

Thousands in Haiti march to demand safety from violent gangs as killings and kidnappings soar

Risky weight loss products often used by teens globally, per study

Moderna hits safety problems in bold bid to reinvent medicine

New England Journal of Medicine addresses racist history, slavery

hotspot

explore

Wikipedia

explore